Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients.
Serio B, Grimaldi F, Ammirati L, Annunziata M, De Santis G, Perrotta A, De Novellis D, Giudice V, Morini D, Storti G, Califano C, Risitano AM, Pane F, Selleri C. Serio B, et al. Among authors: de santis g. Cancer Rep (Hoboken). 2024 Apr;7(4):e2044. doi: 10.1002/cnr2.2044. Cancer Rep (Hoboken). 2024. PMID: 38662362 Free PMC article.
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience.
Serio B, Storti G, D'Addona M, Santoro L, Frieri C, De Novellis D, Marano L, De Santis G, Guariglia R, Manfra I, Urciuoli E, Luponio S, Marotta S, Morini D, Rizzo M, Palmieri F, Cantore N, Giudice V, Risitano AM, Selleri C. Serio B, et al. Among authors: de santis g. Hematol Rep. 2024 Apr 17;16(2):234-243. doi: 10.3390/hematolrep16020023. Hematol Rep. 2024. PMID: 38651452 Free PMC article.
Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil.
Donadel CD, De Santis GC, Gonçalves TE, Pires BG, Palma LC, Gava F, Guerino-Cunha RL, Faria JTB, Silva GVA, Darrigo-Junior LG, Fatobene G, Rocha V, Covas DT, Calado RT, Clé DV. Donadel CD, et al. Among authors: de santis gc. Bone Marrow Transplant. 2024 Apr 13. doi: 10.1038/s41409-024-02283-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38615142 No abstract available.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Assessment and management of postoperative anemia.
Benites BD, Magnus MM, Costa L, Brunetta DM, Rodriges RDR, Alves SOC, De Santis GC, Rizzo SRCP, Rabello G, Junior DML. Benites BD, et al. Among authors: de santis gc. Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1:S72-S76. doi: 10.1016/j.htct.2024.02.014. Epub 2024 Mar 19. Hematol Transfus Cell Ther. 2024. PMID: 38580494 Free article.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Anemia tolerance mechanisms.
Rodrigues RDR, Brunetta DM, Costa L, Benites BD, Magnus MM, Alves SOC, De Santis GC, Rizzo SRCP, Rabello G, Junior DML. Rodrigues RDR, et al. Among authors: de santis gc. Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1:S77-S82. doi: 10.1016/j.htct.2024.02.010. Epub 2024 Mar 19. Hematol Transfus Cell Ther. 2024. PMID: 38575401 Free article.
355 results